Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Parkinson Disease”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Large-scale testing (Phase 3)Study completedNCT04223193
What this trial is testing

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
AbbVie 304
Early research (Phase 1)Study completedNCT04044547
What this trial is testing

LY03003 in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03100149
What this trial is testing

Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 316
Large-scale testing (Phase 3)Study completedNCT00474058
What this trial is testing

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Who this might be right for
Parkinson's Disease
UCB Pharma 287
Not applicableUnknownNCT04033393
What this trial is testing

Dual-task Performance in Young-onset PD

Who this might be right for
Early Onset Parkinson DiseaseEarly Stage Parkinson Disease
National Yang Ming Chiao Tung University 40
Not applicableStudy completedNCT03330470
What this trial is testing

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

Who this might be right for
Subjective Cognitive ImpairmentMild Cognitive ImpairmentParkinson Disease+1 more
Slovak Academy of Sciences 26
Testing effectiveness (Phase 2)UnknownNCT04269642
What this trial is testing

SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease

Who this might be right for
Early Parkinson's Disease
Peptron, Inc. 99
Testing effectiveness (Phase 2)Looking for participantsNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 90
Post-approval studies (Phase 4)Study completedNCT01485172
What this trial is testing

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 186
Testing effectiveness (Phase 2)Study completedNCT06596005
What this trial is testing

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 149
Not applicableEnded earlyNCT00261781
What this trial is testing

Walking Capacity in Parkinson's Disease (PD-Walk)

Who this might be right for
Idiopathic Parkinson's Disease
Natalie Allen 20
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02847650
What this trial is testing

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Who this might be right for
Parkinson Disease
Pfizer 57
Testing effectiveness (Phase 2)Study completedNCT06556173
What this trial is testing

Phase 2a Study of VTX3232 in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson Disease
Zomagen Biosciences Ltd. 11
Post-approval studies (Phase 4)UnknownNCT03727295
What this trial is testing

Idebenone Treatment of Early Parkinson's Diseasesymptoms

Who this might be right for
Oxidative Stress is an Important Cause of Parkinson's Disease
Second Affiliated Hospital of Soochow University 180
Large-scale testing (Phase 3)Ended earlyNCT01028586
What this trial is testing

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 507
Not applicableNot Yet RecruitingNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT00228150
What this trial is testing

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Sanofi 564
Large-scale testing (Phase 3)Ended earlyNCT01155479
What this trial is testing

A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)

Who this might be right for
Parkinson Disease
Merck Sharp & Dohme LLC 1,022
Large-scale testing (Phase 3)Study completedNCT01628965
What this trial is testing

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 143
Load More Results